ADVANCED OCULAR SYSTEMS LTD has a total of 23 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are MELLES GERRIT REINOLD JACOB, HUGHES PATRICK M and GLOUCESTER PHARMACEUTICALS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 5 | |
#3 | Australia | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 3 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Unspecified technologies | |
#5 | Electrotherapy | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Peyman Gholam A | 11 |
#2 | Peyman Gholam Ali | 5 |
#3 | Peyman Gholam | 4 |
#4 | Kellan Robert E | 2 |
#5 | Carroll Simon | 2 |
#6 | John Philip | 2 |
#7 | Sanders Donald Robert | 1 |
#8 | Philip John | 1 |
#9 | Penfold Philip Leslie | 1 |
#10 | Simon Carroll | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007038453A2 | Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation | |
WO2006108239A1 | Ocular drug delivery | |
WO2005102303A2 | Antiprostaglandins for the treatment of ocular pathologies | |
EP1755616A2 | Treatment of exudative retinopathy with mineralcorticoids | |
AU2005216569A1 | Heparin for the treatment of ocular pathologies | |
AU2005216568A1 | Tetracycline derivatives for the treatment of ocular pathologies | |
EP1720555A1 | Tetracycline derivatives for the treatment of ocular pathologies | |
US7083803B2 | Ocular solutions | |
US7087237B2 | Ocular solutions | |
US7083802B2 | Treatment of ocular disease | |
US7354574B2 | Treatment of ocular disease |